{"transactions":[{"id":320,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:03:02.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001267490-26-000010","document":"wk-form4_1788379379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000126749026000010/wk-form4_1788379379.xml","form_type":"4"}},{"id":730520,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T23:13:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":15250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":15250,"derivative":{"exercise_price":1.98,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":15250},"source":{"system":"sec-edgar","filing":"0001267490-26-000008","document":"wk-form4_1782169998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749026000008/wk-form4_1782169998.xml","form_type":"4"}},{"id":737827,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T14:31:49.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.77,"value":8850.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.76 per share to a high purchase price of $1.77 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price."}],"balance_after":10100,"source":{"system":"sec-edgar","filing":"0001267490-26-000006","document":"wk-form4_1781533906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749026000006/wk-form4_1781533906.xml","form_type":"4"}},{"id":737826,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T14:31:49.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":5100,"price":1.745,"value":8899.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.745 per share to a high purchase price of $1.75 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001267490-26-000006","document":"wk-form4_1781533906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749026000006/wk-form4_1781533906.xml","form_type":"4"}},{"id":763820,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:26:47.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.93,"value":19300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.90 per share to a high purchase price of $1.95 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001267490-26-000004","document":"wk-form4_1779827204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749026000004/wk-form4_1779827204.xml","form_type":"4"}},{"id":763819,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:26:47.000Z","date":"2026-05-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.77,"value":17700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.76 per share to a high purchase price of $1.79 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001267490-26-000004","document":"wk-form4_1779827204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749026000004/wk-form4_1779827204.xml","form_type":"4"}},{"id":997650,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-11-17T21:30:11.000Z","date":"2025-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to that certain Purchase Agreement in exchange for cash and CVRs (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to (i) the excess of $1.04 over the per share exercise price of such option multiplied by the total number of shares underlying such in option and (ii) one CVR per share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":0.93,"expiration_date":"2035-02-12","underlying":"Common Shares","underlying_shares":33390},"source":{"system":"sec-edgar","filing":"0001267490-25-000006","document":"form4-11172025_041107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000126749025000006/form4-11172025_041107.xml","form_type":"4"}},{"id":997649,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-17T21:30:11.000Z","date":"2025-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Purchase Agreement, dated August 3, 2025, by and between the Issuer and XOMA Royalty Corporation (as amended, the \" Purchase Agreement\") in exchange for (i) $1.04 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001267490-25-000006","document":"form4-11172025_041107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000126749025000006/form4-11172025_041107.xml","form_type":"4"}},{"id":1003753,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-11T00:30:19.000Z","date":"2025-11-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":3.91,"expiration_date":"2035-11-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001267490-25-000003","document":"wk-form4_1762821015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126749025000003/wk-form4_1762821015.xml","form_type":"4"}},{"id":1140270,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:06:29.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000086","document":"wk-form4_1747771581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148525000086/wk-form4_1747771581.xml","form_type":"4"}},{"id":1263502,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares (Right to Buy)","published_at":"2025-02-19T01:15:24.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":33390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option will vest on February 13, 2026, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting date."}],"balance_after":33390,"derivative":{"exercise_price":0.93,"expiration_date":"2035-02-12","underlying":"Common Shares","underlying_shares":33390},"source":{"system":"sec-edgar","filing":"0001415889-25-004532","document":"form4-02182025_080221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000141588925004532/form4-02182025_080221.xml","form_type":"4"}},{"id":1302629,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-15T21:23:21.000Z","date":"2025-01-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in substantially equal yearly installments beginning on the first anniversary of the grant date such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":40000,"derivative":{"exercise_price":4.9,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001708599-25-000009","document":"wk-form4_1736976192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000009/wk-form4_1736976192.xml","form_type":"4"}},{"id":1352524,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T21:05:27.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000101","document":"wk-form4_1732568717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148524000101/wk-form4_1732568717.xml","form_type":"4"}},{"id":1697847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:46.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060237","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000114036123060237/form4.xml","form_type":"4"}},{"id":2233900,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:26:25.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000051","document":"wf-form4_165515557133787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148522000051/wf-form4_165515557133787.xml","form_type":"4"}},{"id":2665304,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:27:36.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":15097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest on the earlier of the date of the 2022 annual meeting of stockholders of the Issuer and June 16, 2022, the first anniversary of the date of the grant."}],"balance_after":15097,"derivative":{"exercise_price":7.79,"expiration_date":"2031-06-15","underlying":"Common stock","underlying_shares":15097},"source":{"system":"sec-edgar","filing":"0001437749-21-015113","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921015113/rdgdoc.xml","form_type":"4"}},{"id":2796690,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:09:23.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.01,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-005971","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000156761921005971/doc1.xml","form_type":"4"}},{"id":2866280,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2021-02-12T00:24:37.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"price":0,"reported_value":216569.87,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The convertible promissory note (\"Convertible Note\") had a maturity date of June 1, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share."}],"balance_after":0,"derivative":{"exercise_price":16,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001567619-21-003192","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000156761921003192/doc1.xml","form_type":"4"}},{"id":2866279,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T00:24:37.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":18718,"price":11.57,"value":216567.26,"ownership":{"direct":true},"balance_after":18718,"source":{"system":"sec-edgar","filing":"0001567619-21-003192","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000156761921003192/doc1.xml","form_type":"4"}},{"id":3046005,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-08-27T12:17:46.000Z","date":"2020-08-25","kind":"grant","acquired":true,"shares":65700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest annually over three years from the vesting commencement date of August 25, 2020, the date of the grantee's appointment as a director of Vaxart, Inc."}],"balance_after":65700,"derivative":{"exercise_price":6.95,"expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":65700},"source":{"system":"sec-edgar","filing":"0001437749-20-018801","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774920018801/rdgdoc.xml","form_type":"4"}},{"id":3605991,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:11:25.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":302,"price":135.82,"value":41017.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":18385,"source":{"system":"sec-edgar","filing":"0001765581-19-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000039/edgardoc.xml","form_type":"4"}},{"id":3605990,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:11:25.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":276,"price":135.82,"value":37486.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":18687,"source":{"system":"sec-edgar","filing":"0001765581-19-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000039/edgardoc.xml","form_type":"4"}},{"id":3618536,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-05T00:43:28.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":8174,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":8174},"source":{"system":"sec-edgar","filing":"0001765581-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000027/edgardoc.xml","form_type":"4"}},{"id":3618535,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-03-05T00:43:28.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":576,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":576},"source":{"system":"sec-edgar","filing":"0001765581-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000027/edgardoc.xml","form_type":"4"}},{"id":3618534,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-03-05T00:43:28.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":18963,"source":{"system":"sec-edgar","filing":"0001765581-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000027/edgardoc.xml","form_type":"4"}},{"id":3628747,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-02-27T23:40:37.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":230,"price":127.76,"value":29384.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":15463,"source":{"system":"sec-edgar","filing":"0001765581-19-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000010/edgardoc.xml","form_type":"4"}},{"id":3628746,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-02-27T23:40:37.000Z","date":"2019-02-25","kind":"tax_withholding","acquired":false,"shares":310,"price":126.25,"value":39137.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 173 ordinary shares acquired on May 31, 2018 and 73 ordinary shares acquired on November 30, 2018 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":15693,"source":{"system":"sec-edgar","filing":"0001765581-19-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000176558119000010/edgardoc.xml","form_type":"4"}},{"id":3932648,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-05-15T21:27:16.000Z","date":"2018-05-11","kind":"sale","acquired":false,"shares":54,"price":165.005,"value":8910.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":15757,"source":{"system":"sec-edgar","filing":"0001232524-18-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000103/edgardoc.xml","form_type":"4"}},{"id":3932647,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-05-15T21:27:16.000Z","date":"2018-05-11","kind":"sale","acquired":false,"shares":3706,"price":165,"value":611490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":15811,"source":{"system":"sec-edgar","filing":"0001232524-18-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000103/edgardoc.xml","form_type":"4"}},{"id":3964566,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-04-12T20:25:06.000Z","date":"2018-04-10","kind":"sale","acquired":false,"shares":3899,"price":155,"value":604345.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":19517,"source":{"system":"sec-edgar","filing":"0001232524-18-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000076/edgardoc.xml","form_type":"4"}},{"id":4007864,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-03-07T21:10:37.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":302,"price":143.39,"value":43303.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":23416,"source":{"system":"sec-edgar","filing":"0001232524-18-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000060/edgardoc.xml","form_type":"4"}},{"id":4014448,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-05T21:39:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":7319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":7319,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":7319},"source":{"system":"sec-edgar","filing":"0001232524-18-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000049/edgardoc.xml","form_type":"4"}},{"id":4014447,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-05T21:39:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":681,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":681},"source":{"system":"sec-edgar","filing":"0001232524-18-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000049/edgardoc.xml","form_type":"4"}},{"id":4014446,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-03-05T21:39:23.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2018, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":23718,"source":{"system":"sec-edgar","filing":"0001232524-18-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000049/edgardoc.xml","form_type":"4"}},{"id":4026811,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:29:22.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":324,"price":143.8,"value":46591.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":20518,"source":{"system":"sec-edgar","filing":"0001232524-18-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000030/edgardoc.xml","form_type":"4"}},{"id":4026810,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:29:22.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":537,"price":147.44,"value":79175.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 173 ordinary shares acquired on May 31, 2017 and 73 ordinary shares acquired on November 30, 2017 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":20842,"source":{"system":"sec-edgar","filing":"0001232524-18-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252418000030/edgardoc.xml","form_type":"4"}},{"id":4343438,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-04-27T23:10:58.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":1275,"price":160,"value":204000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":21133,"source":{"system":"sec-edgar","filing":"0001232524-17-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000087/edgardoc.xml","form_type":"4"}},{"id":4354358,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This non-qualified stock option is part of an option granted on March 5, 2013 that consisted of an incentive stock option exercisable for 750 ordinary shares and this non-qualified stock option exercisable for 11,250 ordinary shares. The options were fully vested as of March 5, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4354357,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"exercise","acquired":false,"shares":6708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This non-qualified stock option is part of an option granted on August 9, 2012 that consisted of an incentive stock option exercisable for 3,048 ordinary shares and this non-qualified stock option exercisable for 26,952 ordinary shares. The options were fully vested as of August 9, 2016."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":6708},"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4354356,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":6708,"price":152.24,"value":1021225.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22408,"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4354355,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"exercise","acquired":true,"shares":6708,"price":46.83,"value":314135.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":29116,"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4354354,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":4750,"price":152.24,"value":723140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22408,"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4354353,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-04-12T00:29:04.000Z","date":"2017-04-10","kind":"exercise","acquired":true,"shares":4750,"price":59.13,"value":280867.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27158,"source":{"system":"sec-edgar","filing":"0001232524-17-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000082/edgardoc.xml","form_type":"4"}},{"id":4394599,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-08T22:47:24.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, March 5, 2013, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001232524-17-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000076/edgardoc.xml","form_type":"4"}},{"id":4394598,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-08T22:47:24.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":2896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, August 9, 2012, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":2896},"source":{"system":"sec-edgar","filing":"0001232524-17-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000076/edgardoc.xml","form_type":"4"}},{"id":4394597,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-03-08T22:47:24.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":750,"price":59.13,"value":44347.5,"ownership":{"direct":true},"balance_after":22408,"source":{"system":"sec-edgar","filing":"0001232524-17-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000076/edgardoc.xml","form_type":"4"}},{"id":4394596,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-03-08T22:47:24.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":2896,"price":46.83,"value":135619.68,"ownership":{"direct":true},"balance_after":21658,"source":{"system":"sec-edgar","filing":"0001232524-17-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000076/edgardoc.xml","form_type":"4"}},{"id":4394595,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-03-08T22:47:24.000Z","date":"2017-03-06","kind":"tax_withholding","acquired":false,"shares":563,"price":132.81,"value":74772.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":18762,"source":{"system":"sec-edgar","filing":"0001232524-17-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000076/edgardoc.xml","form_type":"4"}},{"id":4400100,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-06T23:57:56.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":7781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":7781,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":7781},"source":{"system":"sec-edgar","filing":"0001232524-17-000063","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000063/edgardoc.xml","form_type":"4"}},{"id":4400099,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-06T23:57:56.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":969,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":969},"source":{"system":"sec-edgar","filing":"0001232524-17-000063","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000063/edgardoc.xml","form_type":"4"}},{"id":4400098,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-03-06T23:57:56.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":19325,"source":{"system":"sec-edgar","filing":"0001232524-17-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000063/edgardoc.xml","form_type":"4"}},{"id":4413662,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2017-03-01T22:17:47.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":935,"price":136.97,"value":128066.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001232524-17-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000123252417000038/edgardoc.xml","form_type":"4"}}]}